Key Insights

Highlights

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

Trial Status

Unknown1

Clinical Trials (1)

Showing 1 of 1 trials
NCT04443361Unknown

Insomnia After the COVID-19 Pandemic

Showing all 1 trials

Research Network

Active Sponsors

  • University of Oslo1
  • Modum Bad1

Top Investigators

Related Conditions

  • Sleep1
  • Insomnia1
  • Anxiety1
  • Depression1

Activity Timeline